ESR1 and breast cancer: We propose that Luminal A breast cancers with higher levels of ER respond to single-hormone stimulation by estrogens, androgens or progesterone by activating the DREAM complex, inhibiting the expression of cell cycle genes and inducing quiescence (Figure 6a).